Clinical Trials Directory

Trials / Unknown

UnknownNCT04574232

SporTRIA Study: A Multicentre Trial for Excretion Kinetics of Triamcinolone Acetonide Following Sport Related Intra-articular Injections in Knees; Definitions of the Washout Periods

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Intra-articular and peri-articular glucocorticoid (GC) injections are common in sports medicine. However, from 1st January 2022, all injectable GC routes (including intra-articular administration (IA)) will be prohibited in-competition by World Anti-Doping Agency (WADA). Due to these rules, an IA GC treatment out-of-competition could result in an adverse analytical finding (AAF) in-competition if the washout period is not clearly defined. The aim of this study is to determine the urinary excretion profile of triamcinolone acetonide following IA to help in the definition of the washout periods.

Conditions

Interventions

TypeNameDescription
DRUGknee intra-articular infiltration with Triamcinolone acetonideknee intra-articular intra-articular ultrasound-guided infiltration of Triamcinolone acetonide

Timeline

Start date
2023-01-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2020-10-05
Last updated
2023-02-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04574232. Inclusion in this directory is not an endorsement.

SporTRIA Study: A Multicentre Trial for Excretion Kinetics of Triamcinolone Acetonide Following Sport Related Intra-arti (NCT04574232) · Clinical Trials Directory